Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ACAD
Recent news which mentions ACAD
< Previous
1
2
3
4
5
6
Next >
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Tickers
ACAD
ADMP
AGEN
ALEC
Tags
News
RCEL
HEPA
From
Benzinga
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Tickers
ACAD
Tags
Market News
FDA PDUFA Date
Benzinga
From
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
RVNC
JNJ
IBB
From
Benzinga
ACADIA Pharmaceuticals's Return On Capital Employed Insights
August 29, 2022
Tickers
ACAD
Tags
Earnings
BZI/ROCE
Market News
From
Benzinga
Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data
August 09, 2022
Tickers
ACAD
VRTX
Tags
Biotech
News
Briefs
From
Benzinga
ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
August 09, 2022
Tickers
ACAD
Tags
ACAD
PT Changes
Price Target
From
Benzinga
NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday
August 09, 2022
Tickers
ACAD
BC
CRSP
MNDY
Tags
Benzinga
Analyst Ratings
TNDM
From
Benzinga
ACADIA Pharmaceuticals: Q2 Earnings Insights
August 08, 2022
Tickers
ACAD
Tags
ACAD
Benzinga
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Tickers
ACAD
AZEK
BALL
BCRX
Tags
BALL
LEGH
AZEK
From
Benzinga
8 Analysts Have This to Say About ACADIA Pharmaceuticals
August 05, 2022
Tickers
ACAD
Tags
Benzinga
ACAD
BZI/AAR
From
Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Tickers
ACAD
AKBA
ALDX
AMRX
Tags
KZIA
BNTX
MRKR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Tickers
AAWW
ACAD
ARRY
ATI
Tags
BCRX
FOXF
RUN
From
Benzinga
Benzinga Before The Bell: Should Investors Worry About Tesla's China Sales, Gold Back In Focus, Nio Smartphone Could Soon Be A Reality Other Top Financial Stories Friday, August 5
August 05, 2022
Tickers
AAPL
ACAD
COIN
INTC
Tags
META
UBSFY
COIN
From
Benzinga
FDA Asks For Additional Study For Acadia's Pimavanserin In Alzheimer's-Associated Delusions
August 05, 2022
Tickers
ACAD
Tags
FDA
Benzinga
Trading Ideas
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
AMGN
PDSB
VIR
From
Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
July 31, 2022
Tickers
ACAD
AMGN
AXSM
BGNE
Tags
Penny Stocks
Benzinga
PFE
From
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers
ACAD
APLS
AVDL
AZN
Tags
JNJ
IBB
DSKYF
From
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Tickers
ABBV
ACAD
ACER
APYX
Tags
General
ACAD
RYTM
From
Benzinga
Acadia Seeks FDA Approval For Genetic Neurological Disorder Candidate
July 18, 2022
Tickers
ACAD
Tags
Market News
FDA
NDA Filing
From
Benzinga
Where ACADIA Pharmaceuticals Stands With Analysts
July 11, 2022
Tickers
ACAD
Tags
Market News
Analyst Ratings
ACAD
From
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Tickers
ACAD
ACER
ALV
AMED
Tags
NN
Movers From Yesterday
GBOX
From
Benzinga
Analysts Try To See Beyond Acadia's Alzheimer's Disease Psychosis
June 21, 2022
Tickers
ACAD
Tags
News
Biotech
Price Target
From
Benzinga
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 33% Today?
June 21, 2022
Tickers
ACAD
Tags
Today's Market
Market News
NASDAQ:ACAD
From
InvestorPlace
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
June 21, 2022
Tickers
ACAD
BHAT
BPT
CNVY
Tags
Market News
Intraday Update
Penny Stocks
From
Benzinga
Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher
June 21, 2022
Tickers
ACAD
ARVL
BHAT
CNVY
Tags
MULN
VALN
ACAD
From
Benzinga
Why Acadia Pharmaceuticals Stock Is Crashing Today
June 21, 2022
Tickers
ACAD
Tags
Recent Press Releases
ACAD
Market News
From
Motley Fool
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Tickers
ACAD
ALV
AMED
ARBK
Tags
VALN
ALV
NERV
From
Benzinga
U.S. Markets Open Higher; Lennar Earnings Top Views
June 21, 2022
Tickers
ACAD
BKSY
CHWY
CNVY
Tags
Benzinga
Penny Stocks
Global
From
Benzinga
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
June 21, 2022
Tickers
ACAD
ACST
AURA
AZN
Tags
News
RXRX
Movers
From
Benzinga
Why Acadia Pharma Shares Are Plunging Today
June 21, 2022
Tickers
ACAD
Tags
Trading Ideas
Benzinga
FDA
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.